Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Congo to start using J&J Ebola vaccine in November

Health authorities in Democratic Republic of Congo will introduce a Johnson & Johnson Ebola vaccine in November 2019 in the country’s eastern provinces, to counter the current outbreak.

Read More »

Bay Area’s Five Prime Slashes 70 Jobs in Second Restructuring of 2019

Five Prime Therapeutics Inc. will eliminate 70 jobs while undergoing a restructuring to extend the company’s cash runway.

Read More »

Roche Vice Chairman Calls for Long-Term Thinking by Business to Save the Planet

Roche Vice Chairman Andre Hoffman is warning that short-term thinking is killing the planet and that corporations must engage in long-term sustainable strategies that limit any environmental harm.

Read More »

OxyContin maker Purdue begins showdown to halt opioid lawsuits

Purdue Pharma LP will ask a U.S. Bankruptcy Judge to pause litigation against the company and ownership over the objections of U.S. states that allege the OxyContin maker is trying to protect the controlling Sackler family.

Read More »

SoftBank-backed Vir Biotechnology raises $143 million in U.S. IPO

Vir Biotechnology priced the company’s initial public offering (IPO) at $20 a share, at the bottom end of expectations, the latest underwhelming investment performance for a stock held by SoftBank Group Corp.’s Vision Fund.

Read More »

International donors to pledge 13.8 billion euros to tackle AIDS: Macron

International donors agreed to pledge 13.8 billion euros ($15.21 billion) to tackle AIDS, said French President Emmanuel Macron.

Read More »

Belgium’s UCB to buy Ra Pharmaceuticals

UCB will acquire U.S.-based Ra Pharmaceuticals in a $2.1 billion deal that will enable the Belgian drugmaker to offer new treatment options for several rare diseases in neurology and immunology.

Read More »

Novo Nordisk, bluebird bio Enter Gene Therapy Pact

Cambridge, Mass.-based bluebird bio and Bagsvaerd, Denmark-based Novo Nordisk agreed to develop next-generation genome editing therapies for genetic diseases, including hemophilia.

Read More »

W2O Acquires Arcus Medica to Accelerate and Deepen Scientific and Medical Communications Offering

W2O – a leading independent provider of analytics-driven, digital-first marketing communications to the healthcare sector – acquired Arcus Medica, a recognized leader in medical and scientific communications.

Read More »

One quarter of every U.S. healthcare dollar wasted

About a quarter of the dollars spent on healthcare in the United States may be wasted, a new analysis suggests.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

October 2019 Focus: Top 50 Company Profiles & Financials, Outcomes Creativity Index, and more!


Ad Right Bottom